BioLite, Inc.

Industry · 7 registered clinical trials — 3 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1 Myelodysplastic Syndrome (MDS)	Phase 2	2027-01-01
Not Yet Recruiting	Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic T Triple Negative Breast Cancer	Phase 1 / Phase 2	2027-01-01
Not Yet Recruiting	A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients Major Depressive Disorder	Phase 1 / Phase 2	2026-01-15
Completed	PDC-1421 Treatment in Adult Patients With ADHD Attention-Deficit Hyperactivity Disorder (ADHD)	Phase 2	2022-04-07
Completed	A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD) Attention-Deficit Hyperactivity Disorder (ADHD)	Phase 2	2019-12-01
Completed	A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Dis Major Depressive Disorder	Phase 2	2015-04-10
Completed	A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression Major Depressive Disorder	Phase 1	2012-11-01